ZBIO

Zenas Biopharma Stock Analysis

AI Rating

Great
  • Quality2/10
  • Growth↑ 9/10
  • Momentum↑ 9/10
Zenas Biopharma sales and earnings growth
ZBIO Growth
Great
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 121.64%
  • FCF Y/Y↓ -64.16%
Zenas Biopharma gross and profit margin trends
ZBIO Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -1266.00%
  • ROIC↓ -174.50%
Zenas Biopharma net debt vs free cash flow
ZBIO Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Zenas Biopharma stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗